Table 4.
Outcomes in patients with BMI <40, CCI 0-3.
| Outcome & narcotic usage | Liposomal bupivacaine PAI | No PAI | P value |
|---|---|---|---|
| Length of stay (d) | 2.64 | 3.06 | 0.004 |
| Narcotic use 0-24 h (mg) | 117.61 | 145.53 | 0.298 |
| Narcotic use 24-48 h (mg) | 110.66 | 182.47 | 0.013 |
| Narcotic use 48-72 h (mg) | 49.61 | 112.65 | 0.004 |
| Walking distance POD 1 (ft) | 73.29 | 59.07 | 0.456 |
| Walking distance POD 2 (ft) | 114.77 | 84.82 | 0.193 |
| Walking distance POD 3 (ft) | 137.27 | 119.38 | 0.545 |
POD, postoperative day; PAI, periarticular injection; BMI, body mass index; CCI, Charlson comorbidity index.